Browse by Track

12-007 - Adverse Effects of Imipenem Following Prolonged Treatment for Mycobacterium abscessus Infections in Children

10-455 - Altered mental status induced by liposomal amphotericin B

10-405 - Angioedema in a patient on everolimus and lisinopril

9-199 - Bromadiolone toxicity following synthetic cannabinoid ingestion

11-430 - Fecal microbiota transplantation for treatment of severe Clostridium difficile colitis in a pediatric oncology patient with anaplastic large cell lymphoma: a case report

11-429 - Impact of doxycycline on diagnosis of malaria in a returning traveler

12-234 - Persistent Cryptococcemia in a Patient with Cryptococcal Meningitis: A Case Report

10-406 - Rare case of linezolid-induced lactic acidosis following prolonged use for suppression of methicillin-resistant Staphylococcus aureus (MRSA)-infected endograft

11-166 - Reduced dose alteplase in the treatment of acute pulmonary embolism

12-337 - Second degree AV block caused by clozapine, divalproex sodium, and haloperidol decanoate

10-408 - Severe euvolemic hyponatremia in a patient cross tapered from carbamazepine to oxcarbazepine

12-006 - Use of ascorbic acid, thiamine and hydrocortisone for the treatment of septic shock in the pediatric intensive care unit

9-205 - Use of ibalizumab in multidrug-resistant human immunodeficiency virus (HIV)

12-049 - An electronic medical record (EMR) based antibiotic time-out results in improved antibiotic therapy

12-058 - Analysis and implementation of patient-specific insulin glargine syringes in the inpatient setting

12-368 - Analysis of pharmacist’s interventions on orders for QTc prolonging medications interaction for patient admitted to the hospital

9-207 - Analysis of the time to administration and accuracy of dosing of 4-factor prothrombin complex concentrate at an academic medical center

10-082 - Antimicrobial Stewardship and The Joint Commission Survey: How a Large Community Hospital is Ensuring Preparedness

11-008 - Assessing penicillin allergy documentation in surgical patients

11-400 - Assessing pharmacist full time equivalents (FTE) for patient care demand in a team based primary care setting

10-302 - Assessment of a bronchopulmonary dysplasia outcome estimator and use of postnatal corticosteroids within two tertiary healthcare centers

13-277 - Assessment of pharmacist competency during cardiopulmonary arrest code participation in a community hospital

11-160 - Assessment of pharmacy bundle services on hospital readmission of congestive heart failure (CHF) and acute myocardial infarction (AMI) patients

11-448 - Characterization of prior antibiotic use in patients with Clostridium difficile infection

13-122 - Comparison of quality and usability of freely available guideline-focused websites following the shutdown of the National Guideline Clearinghouse

13-327 - Cost savings associated with interventions made to inhaled corticosteroid dispensing

10-144 - Deployment of clinical pharmacy services in a primary care physician group

10-454 - Development and galenic validation of an amikacin 0,5% gel used for treatment of cutaneous infections

10-448 - Development and galenic validation of an amphotericin B 1% topic formulation for a refractory fungal infection

11-078 - Development and implementation of a clinical pharmacist position in the operating room

9-155 - Development and implementation of a health system policy for periprocedural management of anticoagulation

11-333 - Development of a primary care-focused post-graduate year two pharmacy residency program in a rural community

12-015 - Digital medicines in chronic care management: using innovative technology to improve health outcomes in high-risk patients

10-003 - Dinoprostone and misoprostol use evaluation across a national health system

11-382 - Enhancing health literacy: the pharmacist’s role in communicating linguistically and culturally appropriate medication education

13-278 - Evaluation of a daptomycin dosing protocol based on adjusted body weight at a community hospital

10-361 - Evaluation of antipsychotics known to cause QTc prolongation in adult intensive care unit patients

10-041 - Evaluation of Daptomycin Dosing and Safety Monitoring in a Hospital Network

10-360 - Evaluation of ketamine for sedation in the intensive care unit (ICU)

11-009 - Evaluation of medications used as part of a rapid response team without a pharmacist in a rural health center

9-145 - Evaluation of protocol based, symptom triggered phenobarbital treatment for alcohol withdrawal syndrome in critically ill patients

13-138 - Evaluation of proton pump inhibitor electronic criteria for use form to guide appropriate prescribing

12-140 - Evaluation of systemic corticosteroid use in septic shock patients across a multi-hospital health system

11-401 - Identification of opportunities for pharmacist intervention for patients with uncontrolled hypertension in the adult primary care setting

12-206 - Impact of group asthma education classes led by a multidisciplinary team in adults for asthma control

12-052 - Impact of Pharmacist education of Nursing Staff on compliance with pain management protocols in a Community Hospital

12-003 - Impact of pharmacist-led medication reconciliation on drug-related problems and potentially avoidable readmissions in Medicare Advantage patients discharged from the emergency department

9-251 - Implementation of a community pharmacy-led transitions of care service on reducing 30-day readmission in patients with chronic obstructive pulmonary disease (COPD)

11-312 - Implementation of a Medication Hotline to reduce post-discharge medication events

11-354 - Implementation of oncology supportive care protocols in an outpatient infusion setting

9-147 - Implementation of pharmacist-led oral chemotherapy education in an outpatient oncology clinic

11-065 - Implementing a pharmacist-led education service to diabetic ketoacidosis (DKA) patients in a community teaching hospital

11-089 - Improving inpatient and outpatient medication-related processes in pediatric patients with epilepsy on the ketogenic diet

11-342 - Patient Characteristics Impacting the Utilization of MyChart Messaging: A Descriptive Analysis

12-045 - Pharmacy Leadership Seminar: Transforming the Profession

12-033 - Practical approach to assess compliance to The Joint Commission pain management standards in a large integrated health care system

12-343 - Real-world experience with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors at a university specialty pharmacy

10-147 - Renal Dosing Appropriateness and Adverse Drug Reaction Incidence for Empagliflozin and Canagliflozin

11-454 - Retrospective chart review comparing a pharmacy-run conservative dosing protocol to manufacturer guidelines for U-100 to U-500R insulin conversions

10-362 - Review and cost analysis of lidocaine patch 5% utilization

10-247 - The impact of University Hospitals Specialty Pharmacy hepatitis C patient management program on patient and pharmacy outcomes

9-208 - The Use of Hormone Replacement Therapy in Gender Non-Conforming Patients Living with HIV

9-431 - 4-Factor prothrombin complex concentrate (4FPCC) dosing strategies: a retrospective evaluation

11-151 - Analysis of a pharmacy resident-driven transitions of care service at a community teaching hospital

10-330 - Analysis of procalcitonin utilization in antimicrobial stewardship

11-217 - Analyzing the hemoglobin A1C lowering effects of glucagon-like peptide-1 agonists in a population of West Virginia Medicaid patients

10-442 - Anticoagulation control of vitamin-K antagonist in pharmacist-led clinic versus physician-led clinic

12-349 - Anti-factor Xa Monitoring of Unfractionated Heparin in Patients on Extracorporeal Membrane Oxygenation (ECMO)

10-456 - Antimicrobial stewardship intervention: institutional guideline concordance is low in cancer patients with febrile neutropenia admitted to general internal medicine at an academic hospital

12-308 - Appropriate use of 4-factor prothrombin complex concentrate: a retrospective study

12-309 - Appropriateness of proton pump inhibitors: a retrospective study

12-019 - Assessing the impact of a pharmacist-led in-service on appropriate antimicrobial utilization in a community hospital

11-252 - Assessing the impact of medication compliance packaging on hemoglobin A1c in diabetic patients receiving oral antiglycemic medications

11-311 - Assessment of Glucose Management with Physician-Driven Insulin Dosing Versus an Electronic Glycemic Management System

10-437 - Assessment of medication devices regulations and healthcare stakeholders' awareness in saudi arabia

10-404 - Assessment of medication reconciliation processes on internal medicine services in a tertiary care academic medical center

10-444 - Bisphosphonate use in hospitalized patients with hypercalcemia of malignancy

9-052 - Categorizing Administration Practices for Vasopressors at Community Medical Centers

9-004 - Characterization of the use of parenteral antibiotics at hospital discharge

12-005 - Ciprofloxacin-dexamethasone otic suspension utilization evaluation to identify potential cost savings at a children’s hospital

9-287 - Comparison of intermittent versus continuous infusion of intravenous pantoprazole in the treatment of upper gastrointestinal bleeds

9-193 - Comparison of renal outcomes in obese versus non-obese patients receiving intravenous acyclovir

13-163 - Compliance and outcome evaluation of hospital-formulated protocol on management of hyperkalemia

11-377 - Cost saving opportunities for a non-profit community hospital to mitigate the effects of losing 340b

13-192 - Dalbavancin sequential treatment for gram-positive bacteremia and infective endocarditis in intravenous drug abusers: a proof of concept evaluation

13-206 - Digoxin immune fab medication use evaluation

11-039 - Drug utilization evaluation of injectable calcitonin for the treatment of hypercalcemia

10-452 - Effectiveness and safety of retreatment of patients with hepatitis C virus infection who previously failed to direct-acting antiviral regimen

10-114 - Effects of a pharmacist-driven acid suppressive therapy stewardship program in children admitted to non-intensive care units

10-447 - Efficacy and Safety of Daclatasvir and Asunaprevir Combination Therapy in Elderly Chronic Hepatitis C Patients

12-026 - Eradication of hepatitis C virus: how does this affect glycemic control in patients with type 2 diabetes mellitus?

12-017 - Evaluating acute kidney injury (AKI) rates with the concomitant use of vancomycin and piperacillin/tazobactam

11-245 - Evaluating appropriateness of anti-Xa level monitoring in patients receiving enoxaparin

11-323 - Evaluating the appropriateness of fentaNYL patch prescribing in a community teaching hospital

12-302 - Evaluating the Rate of Allergy Re-labeling Following a Negative Penicillin Skin Test

13-395 - Evaluating the safety and efficacy of pharmacist and physician dosing and monitoring of warfarin at a three-campus community hospital

9-285 - Evaluating the use of Fidaxomicin for Clostridium difficile infections (CDI) at a large tertiary hospital

10-449 - Evaluating the use of stress ulcer prophylaxis in a tertiary care hospital in the United Arab Emirates

12-008 - Evaluation of a community hospital based pharmacist managed diabetes clinic

12-422 - Evaluation of a diabetic ketoacidosis protocol at a rural community hospital

11-193 - Evaluation of a pharmacist-driven acute coronary syndrome heparin dosing protocol

11-191 - Evaluation of a pharmacist-driven vancomycin pharmacokinetic dosing nomogram

9-173 - Evaluation of accuracy and effective use of fosfomycin

13-383 - Evaluation of albumin 25% use for intradialytic hypotension (IDH)

12-344 - Evaluation of albumin use at an academic medical center

11-158 - Evaluation of appropriate analgesia and sedation prior to neuromuscular blocking agent initiated in critically ill patients

13-065 - Evaluation of appropriate antibiotic prescribing for spontaneous bacterial peritonitis (SBP) prophylaxis in hospitalized adult cirrhotic patients

9-153 - Evaluation of auto-verified, high-risk medication orders on medication safety and optimization in the emergency department

11-130 - Evaluation of burnout among hospital and health-system pharmacists in North Carolina

10-206 - Evaluation of causes and treatment of subtherapeutic international normalized ratios (INRs)

10-083 - Evaluation of ceftaroline utilization in a large community hospital

11-236 - Evaluation of chemotherapy administration within the last 14 days of life

10-333 - Evaluation of chronic obstructive pulmonary disease regimens upon discharge

13-287 - Evaluation of ciprofloxacin criteria of use in an inpatient setting

12-269 - Evaluation of darbepoetin alfa in an acute care teaching hospital

13-208 - Evaluation of diclofenac patches for acute pain in critically ill trauma patients

12-207 - Evaluation of double anti-pseudomonal coverage with amikacin for empiric antibiotic therapy

11-156 - Evaluation of insulin infusions in critically ill patients

11-138 - Evaluation of intravenous phenytoin use in adult patients in the hospital setting

12-391 - Evaluation of levofloxacin use for the treatment of pneumonia in a community hospital setting

10-443 - Evaluation of medication discrepancies upon discharge from intensive care units at an academic medical center in Riyadh, Saudi Arabia

13-027 - Evaluation of off-label uses of subcutaneous rituximab at a health system

13-229 - Evaluation of Patients on Highly Active Antiretroviral Therapy (HAART) in a Community Based Setting

11-155 - Evaluation of phentolamine and hyaluronidase use following extravasation of vasopressors

9-350 - Evaluation of Prescribing Patterns of Quetiapine for Delirium in Critically Ill Patients

10-061 - Evaluation of rabbit antithymocyte globulin use in kidney transplantation

11-161 - Evaluation of risk assessment and documentation for patients on chronic opioid therapy

12-255 - Evaluation of sacubitril/valsartan prescribing at a community hospital

12-042 - Evaluation of sacubitril/valsartan’s effect on hemoglobin A1C, ejection fraction, and/or psychological issues in patients with congestive heart failure at a multidisciplinary clinic

9-333 - Evaluation of Tetanus, Diphtheria and Pertussis (Tdap) vaccination usage in the emergency department of a level I trauma center

11-153 - Evaluation of the appropriateness of stress ulcer prophylaxis in non-emergency department inpatients

13-215 - Evaluation of the effects of pre-hospital administered ketamine for agitation or procedural sedation on hospital length of stay and mechanical ventilation days

13-350 - Evaluation of the implementation of Rx for Change curriculum and student pharmacist perceptions

10-381 - Evaluation of the off-label use of erythropoietin

9-084 - Evaluation of the use of alvimopan in a community hospital

13-289 - Evaluation of the use of electronic criteria for use forms to guide appropriate antibiotic prescribing practices

13-305 - Evaluation of tolvaptan utilization in a tertiary care hospital

10-128 - Evaluation of trends in inappropriate antibiotic prescriptions in pediatric primary care clinics associated with an academic medical center

10-446 - Evaluation of vancomycin dosing in obese patients: a retrospective cohort study

11-154 - Evaluation of vasopressin usage in critical care patients

10-006 - Filgrastim-sndz (Zarxio®) utilization as a biosimilar at an academic pediatric hospital

13-158 - Fosaprepitant (Emend®) for Prevention of Chemotherapy-Induced Nausea and Vomiting: A Medication Utilization Evaluation

9-174 - Glycemic control with evaluative outcomes in diabetic patients undergoing an invasive surgery: a medication use evaluation

13-068 - Heparin dosing in ECMO patients

12-347 - Identifying Gaps in Utilization of Oral Chemotherapy Treatment Plans

11-150 - Impact of a pharmacy-physician collaboration on asthma & chronic obstructive pulmonary disease on emergency department visits

10-138 - Impact of antimicrobial stewardship program on the prevalence of antiretroviral therapy and opportunistic infection related medication errors in a community hospital system

10-441 - Impact of clinical pharmacist-led diabetes management clinic on patient-related health outcomes at an academic tertiary hospital in Saudi Arabia: a prospective cohort study

10-332 - Impact of clotrimazole fungal prophylaxis on tacrolimus exposure in kidney transplant recipients

9-039 - Impact of delaying the initiation of fluoroquinolone prophylaxis in allogeneic hematopoietic stem cell transplantation from day 0 to neutropenia on patient outcomes

11-110 - Impact of interprofessional monitoring and education on the usage of systemic glucocorticoids in acute exacerbations of COPD

12-143 - Impact of letermovir for cytomegalovirus (CMV) prophylaxis on rates of CMV infection in high-risk patients receiving an allogeneic hematopoietic stem-cell transplantation

12-034 - Impact of OnabotulinumtoxinA on Healthcare Resource Utilization in Adult Patients with Chronic Migraine

11-131 - Impact of pharmacist utilization in the hospital discharge medication reconciliation process: a prospective quality improvement study 

9-423 - Impact of pharmacist-delivered inpatient medication counseling on 30-day readmission rates

13-228 - Impact of pharmacy services at an outpatient cardiology clinic

12-406 - Impact of Procalcitonin Guided Antimicrobial Therapy Within a Rural Community Hospital

9-351 - Impact of rapid diagnostic testing and antimicrobial stewardship interventions on time to carbapenem therapy for extended spectrum beta lactamase producing gram-negative bacteremia

9-198 - Impact of treatment of asymptomatic bacteriuria prior to total hip or knee arthroplasty on hospital outcomes

9-146 - Implementation of vancomycin loading using volume of distribution and body mass index

10-445 - Influence of Lauren's subtypes of advanced gastric cancer on response to chemotherapy regimens based on different fluoropyrimidines (fluorouracil or capecitabine):data from the AGAMENON Cancer Registry

11-232 - Inpatient Prescribing Practices of Albumin in an Academic Medical Center

10-005 - Intravenous clonidine use: a retrospective review of adherence to hospital restrictions at an academic pediatric hospital

12-345 - Intravenous immunoglobulin use at an academic medical center: a retrospective observational study to validate current practice

11-226 - Intravenous opioid de-escalation in general medicine patients

13-196 - Is inappropriate documentation of penicillin allergy related to overuse of aztreonam?

9-313 - Medication use evaluation for Antithrombin III concentrate in a large, pediatric, tertiary medical center

9-286 - Medication use evaluation of alteplase in the management of acute ischemic stroke at Baptist Saint Anthony’s Health System

9-305 - Medication use evaluation of ertapenem in a community hospital

9-334 - Medication Use Evaluation of sugammadex at a metropolitan health system

13-172 - Medication use evaluation: albumin use post-cardiothoracic surgery

10-431 - Nonoccupational Postexposure Human Immunodeficiency Virus Prophylaxis in the last 10 years

13-099 - Ondansetron utilization at a community non-teaching hospital

13-367 - Outcomes of a vasopressin continuous infusion protocol in patients with central diabetes insipidus

10-451 - Outcomes with rivaroxaban as a part of triple antithrombotic therapy in atrial fibrillation patients undergoing percutaneous coronary intervention

13-251 - Pharmacist Driven Medication Reconciliation Program Targeted to Patients with a Primary Diagnosis of Acute Decompensated Heart Failure

11-169 - Pharmacist impact on generic utilization of select high cost medications

11-044 - Pharmacist initiated discharge counseling in high-risk patients

9-420 - Pharmacist-led approach to minimize medications errors using medication reconciliation post-discharge and at follow-up

10-331 - Pilot Analysis of Outcomes Between Monitored Anesthesia Care With Dexmedetomidine and General Anesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement

13-070 - Pneumocystis jiroveci pneumonia (PJP) prophylaxis in lung transplant recipients in a large, academic medical center

9-382 - Prescribing Trends of Sulfonylureas versus Other Non-Insulin Antidiabetic Agents in the United States from 2009 to 2015

11-295 - Prospective evaluation of T2Candida panel at a large academic medical center

10-007 - Retrospective chart review of celecoxib use at a pediatric hospital

12-386 - Retrospective drug-use evaluation adherence and persistence differences between extended-release naltrexone injection and buprenorphine-naloxone in Medicaid recipients

12-378 - Retrospective evaluation of a vancomycin dosing per pharmacy protocol within a health system

11-157 - Retrospective evaluation of supratherapeutic vancomycin levels in hospitalized patients

13-211 - Retrospective evaluation of the appropriateness of intravenous hydromorphone and morphine use in the inpatient setting

11-451 - Review of Morphine Dosing Utilizing Finnegan Scoring Scale in the Substance Exposed Newborn Diagnosed with Neonatal Abstinence Syndrome at a Community Hospital

12-041 - Rifaximin for the treatment of septic shock in cirrhotic patients

11-179 - Safety and Efficacy of Low Dose Ketamine in the Emergency Department

12-355 - Safety of intravenous push lacosamide compared to intravenous piggyback

9-172 - Sugammadex use in post-operative reversal of rocuronium bromide or vecuronium bromide in adults undergoing surgery: a medication usage evaluation

13-394 - Sugammadex: Medication use evaluation at a three campus community hospital

12-186 - Surgical opioid stratification (SOS) tool: Standardization of post-operative opioid prescribing practices

13-098 - Surgical site infections: will antibiotics make the cut?

9-100 - The Impact of a Pharmacy-Based Transitions of Care Program on Heart Failure 30-Day Readmission Rates in a Community Hospital

10-440 - The pattern of direct oral anticoagulant use in Saudis' clinical practice, a retrospective cross sectional descriptive study

10-432 - Treatment with omalizumab decreases serious exacerbations in patients with allergic asthma

10-453 - Use of daptomycin in clinical practice: is it improvable?

10-368 - Use of Vitamin Supplementation in a Long-Term Care Facility

11-159 - Utilization trends of albumin five percent at a community teaching hospital

9-235 - 23.4 Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure

10-035 - A Comparative Assessment of Insulin Lispro and Regular Insulin in a Correctional Regimen

13-108 - A comparison of albumin replacement with 4 g/L versus 8 g/L for large-volume paracentesis in cirrhotic patients

13-159 - A Medication Utilization Evaluation for the Appropriateness of Use of Intravenous Chlorothiazide

10-136 - A pre- and post- analysis of outcomes following implementation of a urine culture algorithm in the medical intensive care unit (MICU)

10-273 - A quality assessment of direct oral anticoagulants in an academic medical center

9-119 - A retrospective cohort describing adherence rates to cardiovascular risk reduction guidelines in a single HIV clinic with an embedded pharmacist clinician providing metabolic disease management

9-425 - A retrospective efficacy analysis of decitabine and cytarabine for acute myeloid leukemia (AML) induction therapy

10-223 - A retrospective evaluation of midodrine as a vasopressor-weaning agent in cardiovascular intensive care unit patients

10-299 - A retrospective study to evaluate the impact of sacubitril/valsartan on disease-related outcomes of heart failure patients within an Oregon health-system

13-405 - A Simplified, Specific HPLC Method of Assaying Thiamine, Riboflavin and Niacin in Mushrooms

11-425 - A single centre randomized controlled trial to evaluate dronabinol for acute pain management in adults with traumatic injury

11-060 - A year without belatacept: A comparison of one year outcomes with belatacept conversion for delayed-graft function compared to standard immunosuppression

9-239 - Acceptance of pharmacist-recommended inhaled corticosteroids by primary care providers managing pediatric Medicaid beneficiaries in a managed care organization

13-043 - Acceptance, safety and cost-saving evaluation of a reduced comprehensive metabolic panel schedule in selected breast cancer treatment plans

12-199 - Acetaminophen in advanced cancer pain

9-161 - Acid suppression therapy (AST) and risk of Clostridium difficile infection in solid organ transplant recipients

12-088 - Active pharmacist-led review and intervention pilot utilizing MRSA-negative nasal swab results to reduce empirical vancomycin usage among patients with pneumonia

10-268 - Acute exacerbations of asthma and chronic obstructive pulmonary disease management: a look at outcomes with ipratropium/albuterol dosing frequencies of “around the clock” versus “while awake”

13-001 - Addition of methylprednisolone acetate to dexamethasone sodium phospate/ropivacaine through peripheral nerve block for total knee arthroplasty (TKA): A retrospective cohort analysis

11-095 - Addressing barriers to outpatient insulin adherence during transitions of care

13-301 - Adenosine vs. regadenoson: a post-marketing comparison of side effects, cost, and time taken to perform cardiac stress testing: is regadenoson worth the extra cost?

11-408 - Adherence to analgesia-first sedation in the adult intensive care unit (ICU)

10-195 - Adherence to Pre-Treatment Dental Examinations and Documentation Practices in Oncology Patients Receiving Intravenous Bisphosphonates or Denosumab

9-195 - Adherence to restricted-use policy for inpatient rituximab administration

12-342 - Adherence to updated metformin dosing recommendations in a patient-centered medical home: a comparison of provider-pharmacist team vs. provider only approaches

9-135 - Adult procedural sedation in the emergency department

9-247 - Age & Other GPA Predictors at Howard University College of Pharmacy

11-071 - Alignment of chemotherapy policies to improve medication safety within four Northern Wisconsin oncology centers

13-171 - Alternative alteplase dosing strategies in the ekosonic endovascular system procedure for treatment of pulmonary embolism

11-437 - Alternative thromboprophylactic dosing of enoxaparin: a retrospective analysis evaluating the need for dose adjustments in obesity

11-355 - Ambulatory antimicrobial stewardship for urinary tract infections: a pharmacist implementation study

9-346 - Amiodarone for atrial fibrillation: staying on beat with patient safety

11-391 - An analysis of institutional performance in Centers for Medicare & Medicaid Services outcomes-based quality measure for outpatient cancer care: OP-35

9-056 - An assessment of patient satisfaction related to pain management after the initiation of a pharmacy-led counseling program

12-163 - An Evaluation of Epinephrine Auto-injector Use for Anaphylaxis in a Pediatric Emergency Department

13-241 - An evaluation of nivolumab and pembrolizumab in advanced or metastatic non-small cell lung cancer

12-364 - An evaluation of patient factors that may impact hemoglobin A1c lowering in pharmacist-run collaborative drug therapy management clinics for type 2 diabetes

13-201 - An evaluation of pharmacist led interventions for pediatric patients on ketogenic diets

12-357 - An Evaluation of Vitamin K (Phytonadione) Dosing Practices: Defining the Pharmacist’s Role on Appropriate Dosing and Cost-saving Initiatives

13-193 - An interdisciplinary initiative to increase inpatient and emergency department prescribing of direct oral anticoagulants for patients with venous thromboembolism: a multisite evaluation

12-227 - Analysis following implementation of an updated substitution protocol for inhaled medications

13-402 - Analysis of a pharmacist driven protocol for high- dose methotrexate at a large community teaching hospital

12-409 - Analysis of adverse drug reactions from the use of pre-hospital ketamine: a retrospective observational study

11-300 - Analysis of an antimicrobial stewardship intervention in community-acquired pneumonia (CAP) treatment at a tertiary hospital

9-352 - Analysis of antimicrobial prophylaxis approaches in autologous and allogeneic hematopoietic stem cell transplant recipients

13-364 - Analysis of antiplatelet regimen selection in recurrent ischemic stroke

12-147 - Analysis of Controlled Substance Policy and Procedure at a Community Hospital and Comparison to Best Practice Guidelines

13-323 - Analysis of Converting Insulin Detemir to Insulin Glargine: A Medication Use Evaluation

12-148 - Analysis of current state transitions of care processes for heart failure patients at a community hospital and potential role of the pharmacist

13-174 - Analysis of dose differences of quetiapine in the management of delirium in the intensive care unit

12-396 - Analysis of empiric vancomycin use and the risk factors associated with inappropriate continuation of therapy in a hospital setting

9-072 - Analysis of factors causing hypoglycemic episodes in diabetic inpatients receiving insulin

12-376 - Analysis of Heparin Monitoring Protocol Utilizing the Activated Partial Thromboplastin Time vs Anti-factor Xa in an Academic Medical Center

12-259 - Analysis of hypoglycemic events in an inpatient setting: a medication use evaluation

11-136 - Analysis of pneumonia treatment in a community hospital

12-040 - Analysis of QTc Monitoring Best Practice Alert Integrated into an Electronic Health Record at a Large Academic Medical Center

12-146 - Analysis of services provided to geriatric home-bound patients enrolled in a program for primary care services in the home

11-059 - Analysis of the efficacy of pneumococcal vaccine in a community pharmacy setting

11-239 - Analysis of the etiologies and causative medications in hospital-acquired acute kidney injury

9-044 - Analysis of the treatment of gram negative bacteremia at a community teaching hospital

10-057 - Analysis of the use of empiric double coverage antibiotics for pseudomonas aeruginosa pneumonia in an academic medical center

9-184 - Analyzing the prescribing trends of opioids within Tennessee with HB1831/SB2257 amendment 015082 in a rural pharmacy setting

11-447 - Antibiotic prescribing during transitions of care for hospitalized patients diagnosed with pneumonia

13-011 - Antibiotic prescribing practices within a hospital-affiliated outpatient clinic

12-122 - Antibiotic prophylaxis with vancomycin in cardiac surgery

12-321 - Antibiotic time out: utilizing pharmacy residents and behavioral change techniques to increase effectiveness and sustainability

13-203 - Anticoagulation for Non-ST-Segment Elevation Myocardial Infarction and Unstable Angina in the Emergency Department

9-432 - Anticoagulation in Post-Liver Transplant Recipients with Portal Vein Thrombosis

12-373 - Antiemetic patterns of use and outcomes in a community teaching hospital

12-158 - Antimicrobial stewardship intervention to provide secondary prophylaxis with oral vancomycin for Clostridium difficile infections among high risk patients

13-104 - Antimicrobial stewardship interventions among behavioral health patients

12-179 - Antimicrobial use in cardiac surgery patients with delayed sternal closure

11-215 - Apixaban and rivaroxaban versus warfarin for the treatment of venous thromboembolism in obese patients

13-119 - Approaches to safe adverse event management: a focus on hard-wiring clinical decision making for warfarin reversal and hyperkalemia

9-220 - Appropriate use of albumin at a tertiary care facility: A medication utilization evaluation

13-392 - Appropriate use of epoetin alfa in the treatment of anemia in hemodialysis and continuous renal replacement therapy patients admitted to a community acute care hospital

10-383 - Appropriate Use of Heparin-Induced Thrombocytopenia Lab Panels

11-040 - Appropriate use of intravenous pantoprazole in the emergency department

12-221 - Appropriateness of antibiotics at hospital discharge for the treatment of urinary tract infections in children

11-453 - Appropriateness of discharge opioid prescriptions in opioid-naïve, mechanically-ventilated intensive care unit patients

10-335 - Appropriateness of dosing vancomycin either every 6 or 8 hours and the impact on the incidence of acute kidney injury

10-121 - Appropriateness of international classification of diseases (ICD-10) codes and prescribing practices of acute opioid prescriptions upon discharge

13-073 - Appropriateness of Intravenous Vancomycin Utilization at a Community Teaching Hospital

9-338 - Appropriateness of Rabies Vaccine and Immune Globulin Utilization in the Emergency Department

11-073 - Assessing a diabetic ketoacidosis order set to improve safety and clinical outcomes within an integrated health system

13-268 - Assessing a Sentri7 rule for adult and pediatric human immunodeficiency virus (HIV) patient’s antiretroviral medication regimens in an inpatient setting

11-149 - Assessing acute kidney injury in elderly patients based on vancomycin administration frequency

12-314 - Assessing Antimicrobial Prescribing Patters For Asymptomatic Bacteriuria in the Emergency Department Setting

12-393 - Assessing appropriate de-escalation of antibiotics in urinary tract infections in academic medical centers

12-316 - Assessing Appropriateness of Sugammadex Use in Accordance with Pre-established Pharmacy and Therapeutics Committee Approved Criteria

10-094 - Assessing Barriers to Medication Adherence Among Residents of Jefferson County, Alabama

9-202 - Assessing Behavioral Health Patients' Comprehension of Medication Management Before and After Pharmacist Led Education Sessions

13-113 - Assessing diagnoses and treatments of urinary tract infections at a community hospital emergency department

9-404 - Assessing dispensing status of naloxone prescriptions from a pain clinic

10-183 - Assessing health literacy in a rural setting in order to adapt mobile clinic services to an underserved patient population

13-184 - Assessing impact of a pharmacist-directed erythropoietin stimulating agent dosing protocol at an outpatient community hospital dialysis unit

10-204 - Assessing inappropriate oral dosage form selection and administration of cardiac medications in patients with an enteral feeding tube in an intensive care unit (ICU)

10-113 - Assessing medication-related problems and their association with various patient, system, and clinical factors

13-337 - Assessing outcomes in congestive heart failure patients presenting with septic shock receiving standard versus reduced initial fluid resuscitation volume

10-093 - Assessing outcomes of a newly initiated multidisciplinary culture-review process in the emergency department

11-443 - Assessing patient satisfaction with comprehensive patient care services in a centralized specialty pharmacy

9-204 - Assessing patients' comprehension before and after medication management counseling in a behavioral health setting

13-195 - Assessing pharmacist discharge medication reviews on 30-day hospital readmission rates in patients discharged to skilled nursing facilities

11-260 - Assessing postgraduate year one (PGY1) pharmacy residency candidates’ areas for improvement relative to letters of recommendation

11-214 - Assessing potential complications of a newly implemented daptomycin dosing policy

9-306 - Assessing prescriber perceptions prior to implementation of a pharmacist-physician collaborative practice agreement in the emergency department

9-149 - Assessing readmission rates for thrombosis in patients discharged on anticoagulation therapy after elective total hip or knee arthroplasty

13-355 - Assessing reliability and validity of advanced pharmacy practice experience (APPE) evaluations from one college of pharmacy in the United States

11-270 - Assessing risk of overdose or serious opioid-induced respiratory depression amongst patients discharged from the emergency department with a new or existing opioid prescription

13-183 - Assessing safety and efficacy of intravenous iron supplementation in non-dialysis patients with iron restricted erythropoiesis anemia and concurrent bacteremia

10-392 - Assessing the appropriateness of antibiotic utilization for the treatment of uncomplicated skin and soft tissue infections

10-429 - Assessing the appropriateness of Clostridium difficile toxin assays in hospitalized patients and the effects of pharmacist intervention on patients reported with hospital acquired C. difficile

12-067 - Assessing the appropriateness of opioid prescribing and trauma-associated pain management following major traumatic injury

12-112 - Assessing the Appropriateness of Penicillin Allergy Documentation

10-382 - Assessing the clinical appropriateness and associated drug costs of prescribing lansoprazole orally disintegrating tablets

12-053 - Assessing the Effect of a Penicillin Skin Test Protocol on Fluoroquinolone Usage in a Community Hospital

9-243 - Assessing the effect of continuous glucose monitoring (CGM) on medication adherence and glycemic control in patients with type 2 diabetes

13-335 - Assessing the effectiveness of modafinil as an adjunctive therapy to assist in the weaning of mechanical ventilation

12-063 - Assessing the effectiveness of pharmacist-led standardized medication teaching for combination infusion and oral chemotherapy regimens

9-276 - Assessing the effects education, guidelines and dosing aids have on the safety, efficiency, and confidence in medication dosing during pediatric emergency events

9-187 - Assessing the financial feasibility of implementing clinical services at an independent pharmacy

13-410 - Assessing the impact of a pharmacist led transitions of care team during hospital discharge

12-359 - Assessing the impact of an informational naloxone card on the number of naloxone prescriptions dispensed at community pharmacies located within a health center

12-275 - Assessing the impact of an opioid risk tool (ORT) implemented by medical residents on their opioid prescribing habits

11-048 - Assessing the impact of clinical pharmacy in the management of patients on pre-exposure prophylaxis (PrEP) within adult medicine

13-156 - Assessing the impact of pharmacist intervention on barcode medication administration in the emergency department

11-045 - Assessing the impact of pharmacist-led transition of care services in a primary health care center

11-438 - Assessing the impact of the Colorado alternatives to opioids pilot project to reduce the use of opioids in an acute care emergency department

10-277 - Assessing the impact of translated prescription label directions for Nepalese refugee patients at a community pharmacy

9-048 - Assessing the implementation of guideline-directed sacubitril-valsartan therapy in heart failure

9-246 - Assessing the incidence of medication-related patient safety event reports

9-309 - Assessing the mean tacrolimus trough levels at two weeks and the incidence of rejection post orthotopic heart transplant

11-407 - Assessing the need for neurokinin-1 (NK-1) receptor antagonists in patients receiving carboplatin doses with high emetic potential

13-053 - Assessing the prescribing of direct oral anticoagulants compared to warfarin in patients with extremes in body weight

9-107 - Assessing the prevalence of diabetic retinopathy in well-controlled type 2 diabetes mellitus patients on fibrate therapy

9-439 - Assessing the risk of cardiovascular disease events following testosterone replacement therapy in men

10-305 - Assessing the role of a pharmacy-implemented, standardized probiotic regimen in preventing antibiotic-associated diarrhea and hospital-onset Clostridium difficile infection

13-092 - Assessing the safety and tolerability of flat-rate, 90-minute rituximab infusions at a community oncology center

12-418 - Assessing the safety of piperacillin-tazobactam administered as intravenous push in adult patients

9-061 - Assessing the use of procalcitonin in critically-ill patients with sepsis or septic shock

12-301 - Assessing the volume and rationale of telephone calls from hospital-based health-care providers to the hospital pharmacy: A quality improvement initiative

12-230 - Assessing utilization of local analgesic continuous infusion pumps in post-operative pain management at a community teaching hospital

9-419 - Assessing vancomycin utilization, clinical appropriateness and safety in a community hospital

9-307 - Assessing venous thromboembolism prophylaxis in the liver cirrhosis patient population at a large academic medical center

12-218 - Assessment and efficacy of current alcohol withdrawal syndrome protocol

12-231 - Assessment of a collaborative drug therapy management program in an inpatient geriatric psychiatry unit

10-112 - Assessment of a newly initiated transitions of care clinic at an academic health center

9-324 - Assessment of an opioid stewardship program to decrease opioid exposure for post-surgical pain in pediatric appendectomy patients

10-089 - Assessment of antibiotic de-escalation in the setting of urinary tract infections in a community hospital

12-235 - Assessment of appropriate vancomycin loading doses in serum lactate level reduction in adult patients suspected to have sepsis

10-192 - Assessment of Burnout within a Health-System Pharmacy Department

10-242 - Assessment of calcitonin use at a tertiary medical center

9-156 - Assessment of clinical pharmacist productivity and return on investment after implementation of real-time clinical surveillance technology

9-401 - Assessment of current prescribing practices of adult non-intensive care unit electrolyte replacement in a Midwest tertiary care hospital

10-009 - Assessment of dedicated clinical pharmacist transitions of care services in a rural community hospital targeting patients with congestive heart failure

11-172 - Assessment of direct thrombin inhibitor use in heparin-induced thrombocytopenia

9-430 - Assessment of duration and de-escalation of empiric vancomycin in patients with febrile neutropenia

9-257 - Assessment of dyskalemia with pentobarbital administration using a monitoring protocol

11-261 - Assessment of empiric antifungal therapy in patients with febrile neutropenia

13-179 - Assessment of heparin dosing strategies in the cardiac catherization lab for coronary interventions

13-369 - Assessment of human immunodeficiency virus (HIV) medication associated errors on hospital admission

9-206 - Assessment of implementation of a single insulin infusion protocol in a burn center

9-273 - Assessment of inpatient antibiotic use and patient outcomes in hospitalized adults with febrile neutropenia before and after implementation of an evidence-based standardized electronic plan

12-332 - Assessment of intravenous ascorbic acid, thiamine, and corticosteroids for the treatment of sepsis in a 351 bed community teaching hospital

9-080 - Assessment of intravenous insulin dosing strategies for the treatment of acute hyperkalemia in the emergency department

10-015 - Assessment of intravenous sodium bicarbonate use in critically-ill patients with an acute kidney injury for the treatment of acidosis

11-102 - Assessment of multiple mini- interviews (MMI) and traditional interview techniques in the selection process for postgraduate year 1 (PGY1) pharmacy residency candidates

12-397 - Assessment of multiple variables regarding the correlation between heparin dose and activated clotting time (ACT) in percutaneous vascular intervention angiography

11-284 - Assessment of nicardipine versus labetalol in time to alteplase administration in hypertensive acute ischemic stroke patients in the emergency department

13-319 - Assessment of opioid prescribing in preparation for Joint Commission compliance in a rural community hospital

11-088 - Assessment of outpatient opioid use after total knee arthroplasty

10-254 - Assessment of pharmacist-led warfarin dosing versus non-pharmacist warfarin dosing in an Academic Medical Center

9-280 - Assessment of pharmacy-led discharge counseling service in high readmission risk patients under medical resident care

9-130 - Assessment of post-transplant immunosuppression utilizing immune cell function assays and gene expression profiling

11-085 - Assessment of prescribing patterns of direct oral anticoagulant medications pre- and post- implementation of a pharmacist-led dosing tool

12-383 - Assessment of prescribing patterns of venous thromboembolism prophylaxis after quality improvement interventions at a large, tertiary care, academic medical center: phase 3 of 3

11-218 - Assessment of surgical antibiotic prophylaxis in a community medical center

10-068 - Assessment of the ability of a gamified web-based application to identify opportunities for healthcare intervention in an ambulatory care pharmacy clinic setting

9-142 - Assessment of the appropriateness of urinalysis orders in patients presenting to the emergency department

9-057 - Assessment of the economic and clinical impact of an ambulatory care pharmacist position in an outpatient physician office

12-210 - Assessment of transdermal fentanyl patch utilization in an urban community teaching hospital

12-123 - Assessment of vancomycin dosing in critically ill patients on continuous renal replacement therapy

11-029 - Assessment of vancomycin trough levels post-implementation of bedside barcoding alerts

12-130 - Assessment of venous thromboembolism (VTE) prophylaxis strategies in underweight patients

12-232 - Assessment of warfarin and unfractionated heparin overlap in patients with confirmed venous thromboembolism

11-023 - Association between hospital-acquired Clostridium difficile infections and documentation of beta-lactam allergies

12-157 - Association between warfarin time in therapeutic range and post-transplant outcomes in heart transplant recipients

12-166 - Association of rapid pathogen identification and pharmacist intervention on mortality in patients with bloodstream infections at a community teaching hospital

12-035 - Association of systemic hormone-replacement therapy with risk of cardiovascular events in elderly postmenopausal women

9-097 - Attainment of therapeutic anti-factor Xa levels in morbidly obese patients receiving enoxaparin

12-135 - Augmented renal clearance in the surgical intensive care unit

12-273 - Automated dispensing cabinet optimization and its effect on time to antibiotic administration

13-344 - Automated Dispensing Cabinet optimization: medication utilization review to reduce costs and optimize inventory

9-272 - Automated referral to an ambulatory care pharmacist for patients recently hospitalized with a chronic obstructive pulmonary disease exacerbation: impact on 30-day hospital readmissions

12-369 - Automatic Dispensing Cabinet Inventory Optimization in the Community Hospital Setting

11-446 - Auto-verification versus pharmacist review of select medication orders in the emergency department

10-200 - Barriers to Sepsis Fluid Resuscitation Compliance: Evaluating High-Risk Patients and Fluid Resuscitation Strategies

11-202 - Battling addiction: impact of intravenous drug use on invasive skin and soft tissue management

9-111 - Being smart about our antiretroviral therapy (ART)

13-131 - Belatacept Conversion in a High Risk Urban Renal Transplant Population

13-226 - Benzodiazepine-sparing protocol for the management of alcohol withdrawal syndrome in the critically ill

13-181 - Best practice direct oral anticoagulation process for early-directed deep vein thrombosis therapy to reduce admissions in a large community health care system

11-190 - Beta-blocker therapy for the prevention of doxorubicin-induced cardiotoxicity in patients with cancer: a retrospective cohort study

13-030 - Bone-modifying agent use for adult patients with bone metastases from solid tumors

13-101 - Booster breaks: the effect of pharmacy department work breaks on employee perspectives of coworker relationships

13-026 - Botulinum toxin usage evaluation and potential cost savings across a five hospital health-system

9-116 - Bridging the gap: impact of an infectious disease pharmacist clinician with inpatient antimicrobial prescriptive authority on stewardship

10-099 - Broad-spectrum antimicrobial utilization after new electronic medical record (EMR) implementation

10-355 - Buprenorphine use within acute care hospitals: A medication use evaluation

12-107 - Calcitonin use in hypercalcemia of malignancy

9-016 - Can implementation of a strict protocol for the use of angiotensin II result in better efficacy outcomes in vasodilatory shock?

12-087 - Cangrelor use in an academic medical center: extending beyond the FDA indication

12-024 - Carbapenem-resistant Pseudomonas aeruginosa: risk factors for acquisition and impact on outcomes

12-326 - Cardiovascular risk assessment of HIV-positive patients taking darunavir - A medication utilization evaluation

12-102 - Caving Under Pressure: Management of Hypertensive Crisis

9-295 - Change in geriatric anticholinergic burden during inpatient admission

9-288 - Characteristics associated with overutilization of antibiotics in an outpatient setting for adult acute bronchitis (AAB) in Central Texas

10-267 - Characteristics of neostigmine use for ileus in trauma intensive care unit patients

13-259 - Characteristics of opioid prescribing for acute pain in the emergency department

10-225 - Characterization and management of patients with immune-related adverse events during checkpoint inhibitor therapy

10-365 - Characterization of antibiotic superutilizers in the inpatient setting

9-331 - Characterization of antibiotic therapy for extended-spectrum beta-lactamase-producing Enterobacteriaceae within a county-owned healthcare system

10-373 - Characterization of antibiotic use for acute otitis media in pediatric physician practices

9-021 - Characterization of anticoagulation with ventricular assist devices at a single center

12-408 - Characterization of the current usage patterns of methicillin-resistant Staphylococcus aureus polymerase chain reaction tests and the resulting implications on antibiotic prescribing

10-141 - Characterization of the off-label use of select programmed death-1 and programmed death ligand-1 inhibitors in gynecologic malignancy, associated toxicities and identification of predictors of response

12-390 - Characterization of the treatment of pain in trauma patients in the emergency department at a level I trauma center

10-091 - Characterization of vancomycin dosing required to obtain therapeutic trough level in obese patients: a retrospective chart review

10-213 - Characterizing intravenous pantoprazole use in the pediatric and cardiothoracic intensive care units

12-315 - Characterizing prescribing practices of daptomycin and ceftaroline in a tertiary care hospital

12-075 - Characterizing the impact of pharmacogenomics on patient care in a primary care setting

10-272 - Chemotherapy patient education assessment and quality improvement in an academic medical center oncology outpatient clinic

11-067 - Choosing OTC medications wisely: developing and evaluating an educational outreach program for community dwelling older adults

12-194 - Cirrhosis, thrombosis, finding faXts about doses: dosing of unfractionated heparin for venous thromboembolism in cirrhosis

9-379 - Clinical and economic impact of a pharmacist-initiated interprofessional transitional care management service for Medicare beneficiaries in an ambulatory care clinic

9-344 - Clinical assessment of sub-therapeutic and supra-therapeutic vancomycin levels as a result of a pharmacy dosing and monitoring protocol

10-400 - Clinical consequences in patients experiencing leukopenia and neutropenia after solid organ transplant

12-250 - Clinical effect of the implementation of a subcutaneous insulin order set

13-161 - Clinical Effects of Coaguchek XS PT Test Strips Calibration on Anticoagulation Management Services

9-301 - Clinical Efficacy of Adjunctive Dexmedetomidine Use in the Treatment of Alcohol Withdrawal as Compared to Symptom-Triggered Therapy in Critically Ill Patients

11-250 - Clinical impact and patient perception of pharmacist initiated diabetes self-management education (DSME) in a community-based pharmacy setting

13-093 - Clinical Impact of an Enteral Opiate Optimization Program in the Adult MICU Setting (COELOM)

12-380 - Clinical impact of pharmacist-directed antimicrobial stewardship guidance following rapid diagnostic test results in a healthcare hospital

11-020 - Clinical impact of pharmacists' interventions on general medical-surgical floors

11-275 - Clinical outcomes associated with the use of phenobarbital in patients with alcohol withdrawal syndrome

10-260 - Clinical outcomes in patients following a switch from the infliximab originator to a biosimilar product

9-289 - Clinical outcomes of antibiotics use in patients with uncomplicated adult acute bronchitis

9-355 - Clinical outcomes of neonatal and pediatric patients receiving soybean-based lipid emulsion versus SMOFlipid (fish oil, medium-chain triglycerides, olive oil, and fish oil) lipid emulsion

9-036 - Clinical outcomes of patients requiring reversal of acute major bleeds caused by rivaroxaban or apixaban

12-120 - Clinical outcomes of switching patients to preferred short-acting/rapid-acting insulin products among a commercially insured population

12-126 - Clinical outcomes with extended versus intermittent infusion of cefepime, piperacillin/tazobactam, and meropenem in patients with Gram-negative bacteremia

13-280 - Clinical pharmacist integration into the rapid response team at a community hospital

10-346 - Clinical pharmacy services in a rural level 1 trauma center emergency department: patient and cost benefits

10-104 - Clinical utility of archived HIV-1 DNA sequencing: optimizing antiretroviral therapy in patients with a suppressed HIV viral load

12-188 - Clostridium Difficile Infection management: adaptation of new guidelines into clinical practice

11-237 - Clot in the nick of time: a medication use evaluation of enoxaparin treatment dosing in a multi-site pediatric hospital

12-012 - Code blue training for pharmacists in a community hospital

13-103 - Code sepsis rapid response: implementation of a pharmacist and nurse driven protocol

9-008 - Collaborative approach between pharmacists and nurses to ensure timely medication administration at an acute psychiatric hospital

13-354 - Collecting social determinants of health data and the link to cardiovascular disease risk and intervention: the PRAPARE tool

11-087 - Combining smart pump analytics and incident reporting software to develop an intravenous medication error risk assessment tool

11-001 - Community acquired pneumonia outcomes using an order set compared to no order set

12-348 - Community Pharmacist Collaboration with a Registered Nurse to Improve Guideline Directed Therapy in a Primary Care Facility

9-421 - Community pharmacists’ response to anaphylaxis: an assessment of epinephrine administration knowledge

9-436 - Community pharmacists' role in naloxone distribution during the post-operative period: a retrospective, single center, observational study

12-240 - Comparative evaluation of ertapenem and clindamycin plus gentamicin for the treatment of postpartum endometritis

13-222 - Comparative study of single dose liposomal bupivacaine versus continuous paravertebral block for pain control following video-assisted and robotic-assisted thoracic surgeries

10-170 - Comparing cost and efficacy of utilizing single-shot adductor block with liposomal bupivacaine versus continuous infusion of traditional bupivacaine for pain control after total knee arthroplasty

11-171 - Comparing dinoprostone use and cost to misoprostol for use in cervical ripening procedures across Novant Health

12-340 - Comparing fixed and weight based dosing strategies using 4-factor prothrombin complex concentrate (4PCC) for warfarin reversal

12-164 - Comparing predictors of hospital readmission for high and highest risk patients

13-022 - Comparing rates of acute kidney injury in two empiric antimicrobial regimens at a community hospital

9-427 - Comparing rates of constipation in total knee arthroplasty (TKA) and total hip arthroplasty (THA) patients following implementation of a bowel care program

13-353 - Comparing the accuracy of admission medication reconciliations at Frankfort Regional Medical Center

10-096 - Comparing the choice of second vasopressor in septic shock refractory to norepinephrine

11-233 - Comparing the financial impact of inpatient versus outpatient azacitidine administration

12-329 - Comparison of 30 day re-admission rates in patients receiving oral antiglycemics versus intensive insulin therapy following renal transplantation

9-082 - Comparison of a fixed-dose 4 factor PCC dosing regimen to a weight based regimen for warfarin associated bleeding in a community hospital

13-261 - Comparison of a multimodal stepwise shivering management strategy to a neuromuscular blocker-first strategy for targeted temperature management after cardiac arrest

9-103 - Comparison of acute kidney injury incidence and risk factors in patients receiving vancomycin and cefepime versus vancomycin and piperacillin-tazobactam

10-329 - Comparison of alpha-2a agonists as adjunctive therapy for alcohol withdrawal syndrome

10-209 - Comparison of anti-factor Xa and activated partial thromboplastin time protocols for unfractionated heparin monitoring at a tertiary hospital

9-087 - Comparison of antimicrobial selection in hospitalized patients with documented penicillin allergy before and after nursing education

11-383 - Comparison of Argatroban and Heparin in Pediatric Patients: A Retrospective Case Controlled Review

13-317 - Comparison of breakthrough nausea and vomiting in moderate risk oxaliplatin-based and irinotecan-based chemotherapy regimens: a retrospective chart review

10-018 - Comparison of cefepime dosing strategies in a community teaching hospital

12-363 - Comparison of chlordiazepoxide and lorazepam in symptom-triggered regimens for alcohol withdrawal syndrome: a retrospective cross-site analysis

13-187 - Comparison of clinical outcomes and toxicities targeting high versus low busulfan exposure as measured by area under the curve in myeloablative allogeneic stem cell transplantation

10-364 - Comparison of continuous infusion versus bolus hypertonic saline administration for inducing hypernatremia in the treatment of cerebral edema

10-133 - Comparison of continuous versus intermittent pantoprazole dosing in upper gastrointestinal bleeding: A retrospective cohort

9-388 - Comparison of Efficacy and Safety of Tirofiban versus Eptifibatide in Patients Underwent Percutaneous Coronary Intervention

12-313 - Comparison of electrolyte abnormalities when a phosphate containing versus a non-phosphate containing renal replacement solution is utilized: a retrospective cohort study

12-419 - Comparison of electrolyte profiles in hospitalized patients receiving premixed parenteral nutrition versus customized parenteral nutrition: a retrospective, descriptive study in a community hospital setting

9-049 - Comparison of glucagon-like peptide-1 receptor agonists versus insulin in combination with oral antidiabetics in patients with type 2 diabetes mellitus at an ambulatory care facility

13-295 - Comparison of granulocyte colony-stimulating factor initiation on day +7 versus day +3 after melphalan-based autologous stem cell transplantation

13-334 - Comparison of hemostatic outcomes in anticoagulated patients receiving fixed dose versus weight based 4-factor prothrombin complex concentrate

10-371 - Comparison of high and low intensity heparin protocols on anticoagulation related complications in patients undergoing extracorporeal membrane oxygenation

12-013 - Comparison of high-dose versus standard-dose levetiracetam maintenance therapy in adult patients with status epilepticus

11-192 - Comparison of initial fluid resuscitation regimens in septic obese patients

12-178 - Comparison of intravenous milrinone therapy versus standard hemodynamic augmentation on the severity and duration of symptomatic cerebral vasospasm in patients with aneurysmal subarachnoid hemorrhage (aSAH)

13-413 - Comparison of intravenous push and bolus-only patient-controlled analgesia for managing sickle cell pain and reducing readmissions

11-258 - Comparison of midazolam and propofol sedation strategies in survivors of cardiac arrest during targeted temperature management

11-397 - Comparison of neoadjuvant chemotherapy regimens gemcitabine/cisplatin (GC) and dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin (ddMVAC) in localized bladder cancer

10-218 - Comparison of Non-Opioid Analgesics to Opioid Analgesics for Flank Pain in an Emergency Department after In-Service Education

13-399 - Comparison of opiate requirements in children post-cardiothoracic surgery receiving scheduled acetaminophen with a non-steroidal anti-inflammatory agent versus scheduled non-steroidal anti-inflammatory agent monotherapy

12-066 - Comparison of Oral Stepdown Options for Uncomplicated Gram-Negative Bacteremia in Adults- A Retrospective Analysis

10-029 - Comparison of pharmacist versus prescriber 4T score calculation and HIT antibody results

11-036 - Comparison of pharmacist-initiated versus technician-initiated immunization recommendations in an independent community pharmacy

10-321 - Comparison of postoperative complications after total hip or total knee arthroplasty in patients receiving prophylactic antithrombotic agents in a community hospital setting

9-101 - Comparison of pre and post implementation of a clinical protocol allowing pharmacists to initiate universal MRSA decolonization orders for patients admitted to the ICU

11-280 - Comparison of Prescribing Patterns and Monitoring Parameters of Atypical Antipsychotics between Primary Care Providers and Psychiatrists in a Pediatric Population

9-043 - Comparison of readmission rates between long-acting injectable antipsychotics versus oral antipsychotics

9-240 - Comparison of risk factors for vitamin D deficiency in patients with and without sickle cell disease at an urban ambulatory care clinic

10-279 - Comparison of sugammadex to neostigmine/glycopyrrolate after administration of neuromuscular blocking agents during surgical procedures

9-303 - Comparison of the adjunctive use of ketamine versus standard of care in sedation and analgesic management in patients receiving veno-venous extracorporeal membrane oxygenation

9-003 - Comparison of the effects of intravenous and oral tranexamic acid (TXA) on perioperative hemoglobin levels during total knee arthroplasty

13-157 - Comparison of the efficacy and safety of guideline recommended antibiotics in the treatment of intra-abdominal infections

9-378 - Comparison of the incidence of acute kidney injury (AKI) for adult Hispanic patients on vancomycin treatment as monotherapy or in combination with piperacillin-tazobactam or cefepime

9-105 - Comparison of time to readmission between five long-acting injectable antipsychotics in acutely ill psychiatric patients

12-414 - Comparison of time to shock reversal with hydrocortisone 200 mg/day versus hydrocortisone 300 mg/day in intensive care unit (ICU) patients with septic shock

12-153 - Comparison of two dosing regimens of valganciclovir for cytomegalovirus prophylaxis in high-risk liver transplant recipients

10-001 - Comparison of two heparin protocols for use in extended percutaneous mechanical circulatory support

11-353 - Comparison of vancomycin troughs drawn through a peripherally inserted central catheter (PICC) versus a peripheral line

13-338 - Comparison of vasopressor requirements in mechanically ventilated patients sedated with dexmedetomidine versus propofol

13-018 - Compliance Audit of Titratable Continuous Infusions in the Critical Care Unit at a Tertiary Care Academic Medical Center

11-197 - Compliance with and impact of ciprofloxacin criteria restriction at a tertiary academic medical center

10-350 - Complications of intravenous tissue plasminogen activator (tPA) administration for ischemic stroke in patients greater than 80 years of age

12-098 - Comprehensive evaluation of USP 797 and 800 compliance after implementation of an IV workflow management system at an acute care teaching hospital

13-038 - Comprehensive review of intravenous (IV) cleanroom consumables across a five hospital health system

10-424 - Computerized prescriber order entry (CPOE) order set optimization: a strategy for improving antibiotic utilization

12-023 - Confronting the opioid epidemic through implementation of a pharmacist driven emergency department education program on alternatives to opioids for painful conditions

11-213 - Consequences of dose reduction or discontinuation of renal transplant medications

11-077 - Consolidating and designing a system-wide formulary for a medium sized health system

13-133 - Continuous Furosemide Infusion Following Kidney Transplantation – a Friend or Foe?

10-115 - Conversion from continuous infusion fentanyl to continuous infusion hydromorphone in the pediatric intensive care unit

10-230 - Conversion to a central order processing model: impact on turnaround time, clinical outcomes, employee and patient satisfaction

11-334 - Coordination of inpatient initiation and outpatient continuation of care in a rural health system utilizing Buprenorphine/Naloxone to treat opioid use disorder

13-042 - Correlates and barriers to medication adherence in multiple sclerosis patients and their impact on clinical outcomes

9-241 - Correlating serologic activity from hepatitis B vaccination and CD4 counts in human immunodeficiency virus (HIV) positive patients

12-323 - Correlation between virologic suppression and adherence to antiretroviral therapy, and factors that influence this relationship, in an urban primary care clinic    

13-218 - Correlation of lipophilic and hydrophilic statins to major bleeding events

9-361 - Correlation of supratherapeutic vancomycin trough levels with acute kidney injury (AKI) and other contributing factors in patients at an acute care hospital

10-078 - Cost comparison and utilization of activated prothrombin complex concentrate (aPCC) for anticoagulant-related bleeding

9-046 - Cost comparison of inpatient vs. outpatient modalities for the treatment of antibody mediated rejection in renal transplant patients

13-230 - Cost consequence analysis of single-dose dalbavancin versus standard of care for the treatment of Soft Skin Tissue Infections in a multi-site healthcare system

11-269 - Cost effectiveness of argatroban versus heparin anticoagulation in adult extracorporeal membrane oxygenation patients

12-387 - Cost savings and adherence assessment of an intravenous levothyroxine conservation protocol: One year later

13-388 - Cost savings associated with potential monoclonal antibody dose rounding at a large community teaching hospital

13-041 - Cost savings with erythropoietin stimulating agents in an academic medical center: standardizing weekly dosing days or switching to a biosimilar

11-031 - Cost-effectiveness analysis of outpatient oritavancin infusions for cellulitis

12-050 - Cost-effectiveness evaluation of pharmacist-led conversion from metered-dose inhalers to hand-held nebulizers in a non-teaching community medical center

12-059 - Creating a dashboard to assist in achieving durable medical equipment (DME) and specialty pharmacy accreditation: a county's journey to performance improvement

11-076 - Creating a proposal to implement a specialty pharmacy within in a health system

12-108 - Creation, Implementation, and Evaluation of Pharmacist-led Medicare Part D Open Enrollment Events

10-058 - Current utilization of clinical pharmacists in the emergency department at United States academic medical centers

11-411 - Daily electrolyte replacement and the impact on count recovery in autologous hematopoietic stem cell transplantation

11-235 - Dalbavancin use for acute bacterial skin and skin structure infections in the emergency department at a large rural academic medical center

12-252 - Decreasing excipient exposure in critically ill pediatric patients

13-029 - De-escalation of broad spectrum antibiotics in acute leukemia patients with febrile neutropenia

12-193 - Defining cytomegalovirus viremia thresholds for clinical significance using a WHO-calibrated CMV-PCR assay among solid organ transplant recipients

10-150 - Delays in administration of the second antibiotic dose in severe sepsis and septic shock

13-025 - Denosumab monitoring in oncology patients treated for the prevention and/or management of skeletal related events: a safety and cost optimization assessment/improvement project

12-282 - Deprescribing chronic Proton Pump Inhibitor use to prevent long term adverse events

12-004 - De-prescribing: outcomes of a pharmacist-driven protocol for tapering benzodiazepines

9-218 - Describing current practices of pharmacist-driven dose adjustment of prophylactic enoxaparin in medically-ill, obese patients at an academic medical center

9-438 - Description of bivalirudin anticoagulation in pediatric patients with ventricular assist devices

12-168 - Design and implementation of a hospital guideline for the management of calcium channel blocker and beta blocker toxicity

12-202 - Design, implementation, and assessment of an adverse event monitoring program within a self-funded prescription drug plan

10-051 - Designing a comparison study evaluating discharge diuretic dosing and all-cause thirty-day readmission rates in acute decompensated heart failure patients

10-053 - Designing an evaluation a pharmacist-driven protocol for the treatment of opioid-induced constipation

13-300 - Determination of patient characteristics to identify populations at high risk for medication-related problmes

11-033 - Determining student-level characteristics leading to successful matching in PGY1 community-based residency programs: a curriculum vitae analysis

10-328 - Determining the clinical significance of emergency room admission medication history errors: a comparison of prescribers and pharmacy technicians

11-361 - Developing a pharmacy practice care model for managing medication therapy associated with endocrinology

11-362 - Developing a pharmacy practice care model for proprotein convertase subtilsin-kexin type 9 (PCSK9) inhibitors

11-345 - Developing a standard process for renal function assessment and medication dose adjustment

11-385 - Development and implementation of a multidisciplinary education plan for delirium in the intensive care unit

10-295 - Development and implementation of a pharmacy driven penicillin skin test (PTS) protocol

11-086 - Development and implementation of a sedation guideline for mechanically ventilated patients in a pediatric intensive care unit

12-154 - Development and implementation of a statewide drug shortage network

11-338 - Development and implementation of an educational guideline for piperacillin/tazobactam prescribing in patients

13-411 - Development and implementation of an orientation program and longitudinal ambulatory care rotation for pharmacy residents

12-127 - Development of a clinical risk scoring tool for predicting extended spectrum beta-lactamase colonizations and infections

11-344 - Development of a Comprehensive Anticoagulant Reversal Protocol for a Health System

9-136 - Development of a computerized prescriber order entry (CPOE) chemotherapy order set in a community hospital

10-010 - Development of a medication therapy management scoring index in critically ill patients at a community hospital

12-175 - Development of a pediatric hematology-oncology and blood and marrow transplant population-specific antibiogram: comparison to the hospital-wide antibiogram

11-096 - Development of a scoring system to identify pediatric patients at risk for 30-day readmission

11-363 - Development of a standardized protocol for the use of intravenous vitamin C, thiamine, and hydrocortisone in the treatment of sepsis and septic shock

11-068 - Development of a system-wide automatic dispensing cabinet override formulary and localized override review policy

11-339 - Development of a transitions of care service for congestive heart failure (CHF) and chronic obstructive pulmonary disease (COPD) patients

13-031 - Development of a visual dashboard for a specialty pharmacy

10-013 - Development of an algorithm for clinical decision making regarding intravenous loop diuretics in patients with acute decompensated heart failure

11-405 - Development of an Inpatient Multidisciplinary Diabetes Management Team

9-270 - Diabetic ketoacidosis management: a comparison of a two-bag versus a one-bag system in adult patients

13-052 - Diabetic ketoacidosis: a retrospective evaluation of time to resolution

9-132 - Direct oral anticoagulants for the treatment of venous thromboembolism in cancer patients

11-184 - Discharge opioid prescribing practices

12-392 - Discontinuation of Proton Pump Inhibitors After Treatment of Clostridium Difficile Infection (DC PPI CDI)

12-182 - Diuretic response to furosemide plus albumin vs furosemide alone in surgical intensive care unit patients

13-017 - Documentation of medical marijuana use in cancer patients

12-215 - Does clotrimazole increase the time in therapeutic range of tacrolimus levels in kidney transplant patients in the first month post-transplant

13-132 - Does renal function affect the safety of direct oral anticoagulants for stroke prevention in atrial fibrillation?

9-318 - Does sugammadex reduce post-anesthesia care unit (PACU) length of stay in patients undergoing orthopedic surgery?

11-092 - Door-to-diuretic time in patients presenting with acute decompensated heart failure (ADHF) and the impact of pharmacist-initiated heart failure patient education at an inner city hospital

9-327 - Dosing and monitoring of vancomycin therapy using area-under the curve to minimum inhibitory concentration ratio vs. trough-based measurements

9-254 - Doxycycline versus vancomycin for cystic fibrosis exacerbations among pediatric patients with MRSA colonization

11-282 - Drug use evaluation of methylnaltrexone

9-075 - Drug use evaluation of sliding scale insulin therapy in patients with type 2 diabetes mellitus (T2DM) in a community hospital

13-342 - Drug utilization and cost management study of dinoprostone vaginal insert for cervical ripening

11-281 - Drug utilization evaluation comparing the incidence of acute kidney injury in critically ill patients receiving vancomycin and piperacillin/tazobactam versus vancomycin and cefepime or meropenem

9-180 - Drug-use evaluation of clotting factor concentrates at a pediatric hospital

9-349 - Drug-use evaluation of intravenous immunoglobulin (IVIG) weight-based dosing

9-293 - Duration of antibiotic therapy for Staphylococcus aureus bacteremia in oncology patients

9-260 - Duration of antibiotic use for community-acquired pneumonia and its impact on length of stay and readmission: a retrospective review

9-114 - Effect of a multidisciplinary team on clinical outcomes and medication burden in rural New Mexico

9-373 - Effect of a pharmacist-driven management protocol on the probiotic combination of Lactobacillus strains for prevention of Clostridium difficile infection (CDI) in hospitalized adult patients

10-027 - Effect of a pharmacist-driven medication review on delirium in critically ill patients

10-286 - Effect of a pharmacist-led deprescribing program for antipsychotic use in behavioral and psychological symptoms of dementia

12-191 - Effect of a pharmacist-led interdisciplinary dietary sodium intervention on blood pressure, sodium knowledge, and self-efficacy in patients with Stage 3 and 4 chronic kidney disease

10-387 - Effect of a pharmacist-led methicillin-resistant Staphylococcus aureus (MRSA) nares PCR screening protocol on duration of vancomycin therapy

9-210 - Effect of a reporting system in managing appropriate use of direct-acting oral anticoagulants (DOACs) in the outpatient setting

11-329 - Effect of adjunct midodrine on length of stay in vasopressor-dependent adult ICU patients

9-357 - Effect of adjusted or actual body weight in creatinine clearance calculation on the rates of dofetilide discontinuation or dose reduction during dofetilide initiation

13-398 - Effect of Amitriptyline on Delirium in Trauma Intensive Care Unit (ICU) Patients

10-168 - Effect of audit and feedback on procalcitonin use and duration of antibiotic therapy in patients hospitalized with suspected respiratory tract infections

10-246 - Effect of average inpatient blood glucose greater than 140mg/dL on patient outcomes

13-107 - Effect of cefepime dosage on adverse effects in critically ill adult patients

11-307 - Effect of compliance of enhanced recovery after surgery (ERAS) protocols on pain control at a community medical center

12-192 - Effect of digoxin on right ventricular function in patients with left ventricular assist devices

10-077 - Effect of enhanced recovery after surgery (ERAS) in colorectal patients in a large community hospital

13-333 - Effect of fecal microbiota transplantation in patients with recurrent Clostrioides difficile infection compared to standard antibiotic treatment regimens

11-187 - Effect of Implementation of an eGlycemic Management System® on Time to Target Blood Glucose Range in a Community Hospital System

10-303 - Effect of implementing facility-wide education to increase awareness of Clostridium difficile-related antibiotic stewardship

13-336 - Effect of intensive lifestyle changes on medication therapy for coronary heart disease

11-316 - Effect of intravenous iron on quality of life in patients with congestive heart failure receiving sacubitril/valsartan compared to angiotensin converting enzyme inhibitors

13-409 - Effect of methicillin-resistant Staphylococcus aureus nares culture in suspected pneumonia on antimicrobial stewardship

11-211 - Effect of oral midodrine on duration of intravenous vasopressor therapy and hospital length of stay

12-089 - Effect of peri-procedural heparin versus bivalirudin on bleeding in patients receiving cangrelor for percutaneous coronary intervention at an academic medical center

13-390 - Effect of pharmacist counseling on Hospital Consumer Assessment of Healthcare Providers and Systems scores related to new medication indications and side effect profiles

10-311 - Effect of pharmacist driven pain management education on morphine milligram equivalents dispensed within 60 days status post total hip or knee replacement

11-423 - Effect of pharmacy services on medication-related problems in patients discharging home from the emergency department

10-318 - Effect of prescriber driven antibiotic order end times on duration of therapy in patients diagnosed with community-acquired pneumonia

9-336 - Effect of previous Influenza vaccination on severity of Influenza illness in hospitalized patients

10-095 - Effect of Procalcitonin Monitoring on Antibiotic Therapy Duration in Patients with Pneumonia

9-102 - Effect of procalcitonin protocol on de-escalation of broad spectrum antibiotics in septic and septic shock patients at University Medical Center - New Orleans

10-047 - Effect of renin-angiotensin-aldosterone antagonists and beta blockers on cardiac reverse remodeling after transcatheter aortic valve replacement for severe aortic stenosis

9-422 - Effect of SMOFlipid vs. Intralipid on total parenteral nutrition-induced cholestasis in the neonatal population

10-186 - Effect of sublingual opioid administration on total opioid administration in patients following total knee arthroplasty

9-234 - Effect of targeted prescriber education on comfort and knowledge in the treatment of attention deficit/hyperactivity disorder (ADHD) in a Family Medicine resident clinic

9-362 - Effect of telephonic first-fill counseling for medications received via home delivery on adherence and patient satisfaction in a community pharmacy setting

12-100 - Effect of topical diltiazem gel at 2 percent on management of levator ani syndrome

11-255 - Effect of Using a Standardized Iron Regimen on Blood Transfusion Requirements in Critically-ill, Trauma and Acute Care Surgical Patients

10-123 - Effect of utilizing patient supplied home medication on inpatient medication administration at a large community teaching hospital

12-306 - Effect of vancomycin and piperacillin-tazobactam combination therapy on the incidence of acute kidney injury

9-442 - Effect on Patient Outcomes and Cost Savings After Implementation of a Prothrombin Complex Concentrate (Human)® Dose Standardization and Restricted Use Protocol

11-200 - Effectiveness and safety of metolazone dosing in combination with loop diuretic therapy in acute decompensated heart failure

10-148 - Effectiveness of a post-graduate year one pharmacy resident automatic antimicrobial review at forty-eight to ninety-six hours on appropriate antimicrobial prescribing

13-312 - Effectiveness of adjunctive midodrine therapy for decreasing duration of norepinephrine use in patients admitted to the intensive care unit

11-075 - Effectiveness of ambulatory care pharmacy management and interventions of a regional faith-based health care system

9-047 - Effectiveness of an automated antibiotic time out alert in the setting of gram-negative bacteremia

12-072 - Effectiveness of azithromycin vs. doxycycline in combination with beta-lactams for critically-ill patients with culture-negative community-acquired pneumonia: a cohort study

10-008 - Effectiveness of guideline assisted antibiotic therapy in patients diagnosed with an uncomplicated urinary tract infection (UTI) in an emergency department setting

12-339 - Effectiveness of implementing a medication therapy management program for improving adherence for patients in a community pharmacy

12-267 - Effectiveness of injectable opioid preservation plan implemented in a major New York Academic Medical Center

10-313 - Effectiveness of periarticular infiltration with liposomal bupivacaine versus an alternative joint cocktail for postoperative pain after total knee arthroplasty: a retrospective review

13-321 - Effectiveness of pharmacist review of past urine culture results prior to verification of antimicrobial agent medication order

13-306 - Effectiveness of protocol for decreasing utilization of pantoprazole in the intensive care unit to avoid unnecessary continuation upon discharge

9-358 - Effectiveness of step-down oral beta-lactam antibiotic therapy for Escherichia coli, Proteus mirabilis, and Klebsiella species bacteremia

10-238 - Effects of a comprehensive medication management clinic on high-risk medication use in the elderly

11-241 - Effects of a pharmacist-led initiative to reduce antipsychotic use in patients with dementia

9-077 - Effects of a remote antimicrobial stewardship program on antimicrobial use in a regional hospital system

10-345 - Effects of an antibiotic time-out program for carbapenems in a tertiary teaching hospital

9-158 - Effects of antibacterial surgical prophylaxis on rates of Clostridium difficile

11-050 - Effects of documented penicillin allergy on length of antibiotic treatment and medication cost in an in-patient hospital

10-220 - Effects of educational interventions on appropriate prophylactic antibiotics for prevention of surgical site infections

11-413 - Effects of genomic variances on tacrolimus dosing in kidney transplant recipients

11-204 - Effects of intravenous morphine administration on readmission rates during acute myocardial infarction in a community hospital

13-147 - Effects of liposomal bupivacaine vs. conventional bupivacaine on opioid use for post-surgical pain control following shoulder arthroplasty: a retrospective chart review

10-191 - Effects of pharmacist monitoring and intervention on the timing of subsequent doses of broad-spectrum antibiotics for sepsis of unknown origin

9-316 - Effects of prescribing COPD rescue kits on hospital readmissions

11-005 - Effects of standardized order set modification and pharmacist education on opioid use and prescribing postpartum

12-025 - Effects of Suppressing the Penicillin Allergy Alert for Cephalosporin Orders in an Electronic Health Record

13-266 - Effects of the implementation of a three-day antibiotic time-out at a community hospital

10-049 - Effects of tobramycin pharmacokinetic parameters on safety and efficacy in pediatric cystic fibrosis patients

9-291 - Effects of vancomycin loading doses on patient outcomes

10-399 - Efficacy and Safety of Alemtuzumab vs. Basiliximab Induction in Lung Transplantation

10-342 - Efficacy and Safety of Antipsychotics in Pediatric Intensive Care Unit (PICU) Delirium in Children Less Than 18 Years of Age

12-160 - Efficacy and safety of biosimilar tbo-filgrastim after hematopoietic stem cell transplant

13-368 - Efficacy and safety of bortezomib for the treatment of steroid-refractory chronic graft versus host disease

12-078 - Efficacy and safety of intranasal ketamine for the control of pain in pediatric patients at a level I trauma center emergency department

11-178 - Efficacy and safety of lacosamide in seizure prophylaxis after traumatic brain injury

12-010 - Efficacy and safety of prothrombin complex concentrates for the emergent reversal of oral factor Xa inhibitors in the Emergency Department

12-196 - Efficacy and Safety of Push Dose Phenylephrine in Adult ICU Patients

13-221 - Efficacy and safety of systemic heparin and bivalirudin in adult patients supported by extracorporeal membrane oxygenation

13-054 - Efficacy of a nurse driven diabetic ketoacidosis protocol on diabetic ketoacidosis treatment and serum osmolarity

10-275 - Efficacy of alteplase 1 mg in restoring function to central venous access devices

13-102 - Efficacy of established direct oral anticoagulants in obese patients

11-285 - Efficacy of fidaxomicin vs oral vancomycin in the readmission rates of high-risk patients with Clostridium difficile

9-424 - Efficacy of heparin protocols with and without boluses

13-360 - Efficacy of ketorolac for treatment of acute pain among elderly patients in the emergency department

10-043 - Efficacy of melatonin for the prevention of intensive care unit (ICU) delirium

12-039 - Efficacy of methenamine hippurate for treatment of urinary tract infections

11-003 - Efficacy of midodrine to decrease intravenous vasopressor requirements in ICU patients

12-277 - Efficacy of the three-dose hepatitis B vaccine: real world data

10-025 - Efficacy of twice-daily aspirin versus direct-acting oral anticoagulants for the prevention of deep venous thrombosis and pulmonary embolism after orthopedic surgery

13-061 - Efficacy of using antipsychotics as adjunct therapy to benzodiazepines in severe alcohol withdrawal

11-414 - Electrolyte abnormalities and their associated risk with the development of atrial fibrillation in patients following autologous hematopoietic stem cell transplant

9-400 - Electronic medical record 48-hour antimicrobial timeout best practice alert: evaluation of implementation in an acute care setting

11-220 - Emergency department visits for skin and soft tissue infections related to injectable drug use between two hospitals in Huntington, West Virginia

10-030 - Emergent reversal of oral factor Xa inhibitors with prothrombin complex concentrates

11-041 - Empiric antibiotic guideline compliance in an observation unit

11-452 - Empiric use of methylnaltrexone in postoperative orthopedic patients

13-326 - Enteral naloxone for opioid-induced constipation: a single pediatric intensive care unit experience

13-257 - Enteral nutrition in critically ill patients with concurrent vasopressors: is it safe

10-269 - Enterobacteriaceae bloodstream infections and comparative efficacy of oral step-down antimicrobial therapy

10-127 - Epstein Barr virus viremia in pediatric solid organ transplant patients: a retrospective chart review

11-424 - Evaluate beneficial outcomes of utilizing rapid culture and disk diffusion methods to identify pathogens and resistance patterns in positive blood cultures at Saint Anthony Hospital

12-099 - Evaluate the clinical effectiveness of an interdisciplinary collaborative care in poor controlled diabetes type 2 patients

12-061 - Evaluate the implementation of oral chemotherapy order sets in an outpatient cancer center

13-233 - Evaluate the usage of Ceftriaxone for open fracture infection prophylaxis: a retrospective analysis

11-051 - Evaluating a correlation between outpatient antibiotic prescriptions and onset of community acquired-clostridium difficile infection (CA-CDI) in adults

13-140 - Evaluating a formulary substitution of inhaled fluticasone to nebulized budesonide

11-146 - Evaluating a new tool to optimize the medication history process

13-244 - Evaluating adherence to an institutional insulin infusion protocol for critical care patients in a community healthcare system

10-024 - Evaluating antibiotic selection for physician compliance with urinary tract infection electronic medical record (EMR) care pathways in a community hospital

11-331 - Evaluating approaches to reduce delay of first and second dose antibiotics in patients admitted for sepsis and septic shock

10-374 - Evaluating appropriateness of albumin use at a small community hospital

9-225 - Evaluating appropriateness of epoetin alfa prescribing at a community hospital

9-411 - Evaluating argatroban use and a rapid laboratory test to detect heparin-induced thrombocytopenia: a pharmacy and laboratory collaboration

9-278 - Evaluating compliance with current guidelines for diagnosis and treatment of clostridium difficile infections in a community hospital

12-356 - Evaluating cost reductions in antibiotic use in relation to pharmacist interventions: a retrospective analysis of clinical and economic outcomes in a community hospital setting

13-377 - Evaluating diabetic ketoacidosis protocol usage

13-112 - Evaluating Direct Oral Anticoagulant Prescribing Practices and Impact on Patient Outcomes

10-325 - Evaluating melatonergic and non-pharmacologic therapies in preventing geriatric delirium

12-229 - Evaluating naloxone use in the emergency department of an urban community hospital

13-420 - Evaluating Optimal Antibiotic Duration of Therapy in Hospitalized Patients with Gram Negative Bacteremia

9-060 - Evaluating patients presenting to the emergency department with hypoglycemia or hyperglycemia at an urban tertiary medical center - a root cause analysis

11-350 - Evaluating pharmacist impact on new-start SSRI/SNRI adherence and therapy in adult patients in the primary care setting

10-117 - Evaluating pharmacy interventions in the emergency department of a rural community hospital: a pilot project

10-334 - Evaluating Prescribing Practices of Intravenous Iron Therapy in Non-Hemodialysis Patients

9-228 - Evaluating prevalence and outcomes of patients with substance use disorders and infective endocarditis

9-370 - Evaluating prothrombin complex concentrate (PCC) door to administration time in anticoagulant associated intracranial hemorrhage patients in the emergency department

13-358 - Evaluating Quality of Care: Analysis of the impact of a clinical pharmacy program on the diabetes care of an underserved population within a medical home

12-011 - Evaluating risk factors associated with rituximab infusion-related reactions in oncology patients

13-372 - Evaluating sacubitril/valsartan prescribing practices in patients with reduced ejection fraction heart failure

12-266 - Evaluating the appropriate use of opioids and naloxone in an acute care setting

9-339 - Evaluating the Appropriate Use of Tdap Vaccine in the Emergency Department

9-038 - Evaluating the appropriateness of enoxaparin dosing for venous thromboembolism prophylaxis in obese patients

9-308 - Evaluating the characteristics and outcomes of prescribing practices of direct oral anticoagulants vs. vitamin K antagonist for therapeutic anticoagulation in obese patients

12-124 - Evaluating the clinical interpretation of the anti-platelet factor 4 assay (PF4 ELISA) in the absence of reported optical density units

9-233 - Evaluating the dual impact of dose and time to administration of IV loop diuretics in acute heart failure patients

12-299 - Evaluating the effect of a pharmacy resident’s interventions toward reducing opioid prescribing in a community teaching hospital

9-322 - Evaluating the effectiveness of an educational tool in assisting pharmacists in cancer treatment management

10-401 - Evaluating the effectiveness of multidisciplinary inhaler optimization on 30-day hospital readmissions for patients with chronic obstructive pulmonary disease

12-300 - Evaluating the effects of a pharmacist-directed vancomycin dosing and monitoring program at a community teaching hopsital

9-167 - Evaluating the effects of aromatherapy on neonates with neonatal abstinence syndrome

13-293 - Evaluating the effects of in-clinic patient conducted blood pressure measurements on workflow in a rural clinic

12-121 - Evaluating the efficacy and safety of a heparin nomogram in cardiovascular surgery patients at a pediatric institution

9-259 - Evaluating the efficacy of Exparel at providing postoperative analgesia in patients undergoing cholecystectomy

12-362 - Evaluating the efficacy of gradual dose reduction (GDR) for reducing antipsychotic medication use in nursing home patients: a single center retrospective study

10-386 - Evaluating the impact of a nurse case manager-led program on a hemophilia population

11-288 - Evaluating the impact of a pharmacy patient assistance coordinator at a community hospital

11-315 - Evaluating the impact of advanced pharmacy practice experience (APPE) students providing medication therapy management services within an ambulatory care rotation

13-066 - Evaluating the impact of an intravenous opioid restriction in response to national shortages

10-181 - Evaluating the impact of GLP-1 agonists on metabolic changes in patients with type 2 diabetes and intensive insulin regimens

10-020 - Evaluating the impact of implementation of rapid Blood Culture Identification (BCID) on time to targeted antibiotic therapy in a community hospital

9-185 - Evaluating the impact of influenza and streptococcal point of care testing and collaborative practice prescribing in a community pharmacy setting

10-154 - Evaluating the impact of pharmacist-led interventions in an underserved diabetic population

10-119 - Evaluating the impact of pharmacist-led interventions on smoking cessation in an established outpatient medication management clinic

12-195 - Evaluating the implementation of premedications prior to pegaspargase infusions in pediatric acute lymphoblastic leukemia patients

13-352 - Evaluating the incidence and outcomes of hepatitis C through pharmacist-led screenings in an opioid-use disorder protocol program

9-304 - Evaluating the management of patients recovering from septic shock: a retrospective before and after shock protocol study

10-182 - Evaluating the need and efficacy of Mental Health First Aid (MHFA) training to enhance pharmacy students’ knowledge of depression and anxiety

9-249 - Evaluating the outcomes associated with adjusted enoxaparin dosing versus non-adjusted enoxaparin dosing in obese patients requiring therapeutic anticoagulation

10-243 - Evaluating the potential role of statin therapy in the reduction of gentamicin-induced nephrotoxicity: A retrospective cohort study